Related Experiment Video
Updated: Jun 26, 2026

14:22
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
Published on: July 16, 2011
Forward RNAi screens in primary human hematopoietic stem/progenitor cells
Nicole Ali1, Christine Karlsson, Marie Aspling
1Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Blood
|February 4, 2009
Summary
Researchers developed a new screening method to identify genes that control hematopoietic stem and progenitor cell (HSPC) self-renewal and differentiation. This approach successfully identified novel targets influencing human hematopoiesis.
Area of Science:
- Stem cell biology
- Hematopoiesis
- Molecular screening
Background:
- Mechanisms governing hematopoietic stem and progenitor cell (HSPC) self-renewal and differentiation are not fully understood.
- Identifying regulators of these processes is crucial for understanding human hematopoiesis.
Purpose of the Study:
- To develop and apply a novel screening strategy to identify modulators of human hematopoiesis.
- To assess gene targets that influence the self-renewal and differentiation of human HSPCs.
Main Methods:
- Utilized a lentiviral short hairpin RNA (shRNA) library transduced into cord blood-derived stem/progenitor cells.
- Employed functional selection based on the limited persistence of HSPCs in ex vivo culture to identify shRNAs enhancing stem/progenitor potential.
- Conducted pooled screens in large cell populations.
Main Results:
- Identified novel specific gene targets, including exostoses 1, that modulate human hematopoiesis.
- Discovered shRNA constructs capable of altering human hematopoietic progenitor differentiation and stem cell expansion.
- Demonstrated the efficacy of the forward screening approach in primary human stem cell populations.
Conclusions:
- The developed screening strategy is effective for identifying modulators of human hematopoiesis in primary stem cell populations.
- This approach provides a powerful tool for discovering novel gene targets regulating stem cell fate decisions.
- The findings advance the understanding of regulatory mechanisms in human hematopoiesis.

